{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:15:42Z","timestamp":1761178542712,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.canrad.2019.07.124","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T17:44:56Z","timestamp":1566927896000},"page":"496-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radioth\u00e9rapie des oligom\u00e9tastases\u00a0: principaux essais en cours et \u00e0 venir en France"],"prefix":"10.1016","volume":"23","author":[{"given":"P.","family":"Giraud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tournat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kreps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-E.","family":"Bibault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dautruche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Feutren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Durdux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2019.07.124_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.07.124_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/713073","article-title":"Stereotactic body radiotherapy for metachronous multisite oligo-recurrence\u00a0: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature","volume":"2012","author":"Onishi","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.canrad.2019.07.124_bib0065","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2019.07.124_bib0070","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1200\/JCO.2012.45.9651","article-title":"Extracranial oligometastases: a subset of metastases curable with Stereotactic Radiotherapy","volume":"11","author":"Corbin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.07.124_bib0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cncr.23209","article-title":"A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5\u00a0or fewer oligometastatic lesions","volume":"112","author":"Milano","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2019.07.124_bib0080","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jjco\/hyq044","article-title":"Clinical outcomes of stereotactic brain and\/or body radiotherapy for patients with oligometastatic lesions","volume":"40","author":"Inoue","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.07.124_bib0085","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/cncr.26611","article-title":"Stereotactic body radiotherapy for multisite extracranial oligometastases: fi nal report of a dose escalation trial in patients with 1\u00a0to 5\u00a0sites of metastatic disease","volume":"118","author":"Salama","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2019.07.124_bib0090","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.ijrobp.2008.03.044","article-title":"Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy","volume":"72","author":"Milano","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2019.07.124_bib0045","first-page":"4","article-title":"Stereotactic radiotherapy for oligometastasis","volume":"11","author":"Otake","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2019.07.124_bib0095","first-page":"1","article-title":"Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer","volume":"5","author":"Shah","year":"2013","journal-title":"Cancer"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321819302987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321819302987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:32:32Z","timestamp":1761136352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321819302987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1278321819302987"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2019.07.124","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie des oligom\u00e9tastases\u00a0: principaux essais en cours et \u00e0 venir en France","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2019.07.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}